| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 01/07/2009 | EP1684735A4 Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias |
| 01/07/2009 | EP1455840B1 Treatment of human soft tissue sarcoma with adenoviral vector expressing tnf-alpha |
| 01/07/2009 | EP1407008B1 Influenza vaccine composition |
| 01/07/2009 | CN101337922A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 01/07/2009 | CN100448893C Humanized antibodies that recognize beta amyloid peptide |
| 01/07/2009 | CN100448863C 抗生素化合物 Antibiotic compound |
| 01/07/2009 | CN100448852C Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 01/06/2009 | US7473787 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
| 01/06/2009 | US7473686 Thrombopoietin mimetics |
| 01/06/2009 | US7473432 NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 01/06/2009 | CA2395331C Pharmaceutical compositions providing enhanced drug concentrations |
| 01/01/2009 | US20090005551 Coupling silylated 5-azacytosine to a protected ribofuranose using trimethylsilyl trifluoromethane catalyst; cooling, accumulation by filtration, quenching, solvent extraction |
| 01/01/2009 | US20090005534 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 01/01/2009 | US20090005451 Compounds for the treatment of metabolic disorders |
| 01/01/2009 | US20090005318 Controlled release composition and method of producing the same |
| 01/01/2009 | US20090005293 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 01/01/2009 | US20090004723 Methods and Compositions Concerning Poxviruses and Cancer |
| 01/01/2009 | US20090004257 Transdermal administration of fentanyl and analogs thereof |
| 12/31/2008 | EP2009042A1 Anion-binding polymers and uses thereof |
| 12/31/2008 | EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| 12/31/2008 | EP1192125B1 Mono-substituted 3-propyl gamma-aminobutyric acids |
| 12/31/2008 | CN101333184A Processes for the preparation of (r)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4 piperidinemethanol |
| 12/31/2008 | CN101332300A Dosages for treatment with anti-egfr antibodies |
| 12/31/2008 | CN101332299A Dosages for treatment with anti-egfr antibodies |
| 12/31/2008 | CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 12/31/2008 | CN100446811C Composition comprising immunogenic microparticles |
| 12/31/2008 | CN100446767C Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 12/30/2008 | US7470681 Pyrimidine compounds |
| 12/30/2008 | US7470662 Method of reducing the likelihood of implantation failure during an assisted reproduction in a female subject in a need thereof |
| 12/30/2008 | US7470435 Pellets containing binder |
| 12/30/2008 | US7470397 Disintegratable films for diagnostic devices |
| 12/30/2008 | CA2501601C Method of treating insulin resistance, adult onset diabetes and metabolic syndrome x using small unilamellar vesicles |
| 12/30/2008 | CA2429850C Ep4 receptor selective agonists in the treatment of osteoporosis |
| 12/30/2008 | CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 12/30/2008 | CA2405856C Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
| 12/30/2008 | CA2391293C .beta.2-adrenergic receptor agonists |
| 12/30/2008 | CA2365079C Antiperspirant structured emulsion compositions |
| 12/30/2008 | CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 12/30/2008 | CA2309302C Dyeing composition for keratinous fibres with a cationic direct colouring agent and a silicone |
| 12/30/2008 | CA2304958C Bioadhesive compositions and methods for topical administration of active agents |
| 12/25/2008 | US20080319183 Branched Polymeric Sugars and Nucleotides Thereof |
| 12/25/2008 | US20080318862 Crosslinkable polymeric materials and their applications |
| 12/25/2008 | US20080318231 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer type |
| 12/25/2008 | US20080317776 Vaccines Containing Viruses Involved in Avian Malabsorption Syndrome and Methods of Administration Therefor |
| 12/24/2008 | EP2006301A1 Peptide-based immunization therapy for treatment of atherosclerosis |
| 12/24/2008 | EP1620102B1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 12/24/2008 | EP1603555B1 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 12/24/2008 | EP1549340B1 Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 12/24/2008 | EP1545502A4 Keto cannabinoids with therapeutic indications |
| 12/24/2008 | CN101328163A Compounds, compositions and methods |
| 12/24/2008 | CN101328150A 新的苯并咪唑衍生物 New benzimidazole derivatives |
| 12/24/2008 | CN101327326A Vaginally administered anti-dysrhythmic agents for treating pelvic pain and infertility |
| 12/24/2008 | CN101327196A Dosage form and method for administering drug |
| 12/24/2008 | CN100444840C Method for reducing amyloid deposition, amyloid neurotoxicity and microgliosis |
| 12/23/2008 | US7468440 Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| 12/23/2008 | US7468437 useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P; treatment of certain disorders, including emesis, depression, and anxiety |
| 12/23/2008 | CA2386627C Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 12/23/2008 | CA2306393C Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization |
| 12/18/2008 | US20080312449 New Compounds |
| 12/18/2008 | US20080312310 Compounds, Compositions and Methods |
| 12/18/2008 | US20080312219 Biologically active methylene blue derivatives |
| 12/18/2008 | US20080312173 Treatment of HSV-related pathologies using plasmids that make ssDNA |
| 12/18/2008 | US20080311556 Sense Antiviral Compound and Method for Treating Ssrna Viral Infection |
| 12/18/2008 | US20080311156 Vaccines |
| 12/17/2008 | EP1684744A4 Pyrrolidine and piperidine derivatives as factor xa inhibitors |
| 12/17/2008 | EP1651623B1 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 12/17/2008 | EP1628622A4 Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements |
| 12/17/2008 | EP1614426B1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 12/17/2008 | EP1610796A4 High potency dopaminergic treatment of neurological impairment associated with brain injury |
| 12/17/2008 | EP1395271B1 Herbal compositions for the treatment of mucosal lesions |
| 12/17/2008 | EP1282609B1 Piperazinedione compounds |
| 12/17/2008 | CN101322846A Compositions containing inclusion complexes |
| 12/16/2008 | US7465836 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 12/16/2008 | US7465800 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 12/16/2008 | US7465462 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
| 12/16/2008 | US7465448 Chemokine receptor antagonists as therapeutic agents |
| 12/16/2008 | US7465445 Methods of preventing or treating graft versus host reaction by administering an antibody or portion thereof that binds to AILIM |
| 12/11/2008 | WO2004105684A3 Combination therapy for proliferative disorders |
| 12/11/2008 | WO2004093825A3 Methods for obtaining colonization factors from bacterial strains |
| 12/11/2008 | US20080306139 isolated from a fermentation broth of eubacterium Streptomyces sp. cultures; effective in the treatment of bacterial infections |
| 12/11/2008 | US20080305097 Use of Protease or a Protease Inhibitor for the Manufacture of Medicaments |
| 12/10/2008 | EP1673085A4 C-met modulators and methods of use |
| 12/10/2008 | EP1613300B1 Photostabilized topical formulations of ketoprofen containing two uv filters |
| 12/10/2008 | EP1590001B1 Method for in vivo regulation of cardiac muscle contractility |
| 12/10/2008 | EP1252893B1 Medicine containing anemonin as effective component for treating aseptic inflammation |
| 12/10/2008 | CN100441674C Branched sulfates with improved odor properties and their use in personal care compositions |
| 12/09/2008 | US7462643 Essential fatty acids in the prevention of cardiovascular events |
| 12/09/2008 | US7462629 Therapy or prevention diseases caused by lymphocyte interaction; antiinflammatory agents; autoimmune disease |
| 12/09/2008 | US7462610 Prostate cancer treatment |
| 12/09/2008 | US7462593 Compositions and methods for promoting angiogenesis |
| 12/09/2008 | US7462361 N,N-dihalogenated amino acids and derivatives |
| 12/09/2008 | US7462353 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis |
| 12/09/2008 | US7462232 Microcrystalline cellulose compositions |
| 12/09/2008 | CA2294059C New amidino derivatives and their use as thrombin inhibitors |
| 12/04/2008 | WO2007092161A3 A direct cellular energy delivery system |
| 12/04/2008 | WO2005020922A3 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 12/04/2008 | US20080300179 Bowman-Birk Inhibitor Compositions for Treatment of Muscular Atrophy and Degenerative Muscle Disease |
| 12/04/2008 | US20080300175 Glycopegylated erythropoietin |
| 12/04/2008 | US20080299639 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation |
| 12/04/2008 | US20080299005 film made of water soluble polymer such as hydroxypropyl cellulose, hydroxymethyl propyl cellulose, a reagent such as protein, hormone, antibody and an enzyme; film disintegrates upon contact with an aqueous fluid to release the reagent which reacts human chorionic gonadotrophin in saliva, urine, blood |